It has been a while since we looked at Massachusetts’ experience with health care reform, but a new report from the state gives us an opportunity to do so. (Mass. Mkt. Report) The report contains a great deal of useful information, but the very concentrated structure of the Massachusetts payer and provider markets may not make the lessons applicable to all states. Most of the analysis relates to commercial insurance, which covers about 62% of residents, a total which has declined since the state reform. About half the commercial market is self-insured employers. Blue Cross has 45% of the commercial market and the three largest payers have 80%. Don’t expect much competition. The average monthly premium was $421 in 2011, up 9.7% since 2009, almost double the rate of inflation. That is $5000 a year, but all that money is buying less value, the benefits have declined 5.1% in the same period, largely due to higher deductibles and copays, so really the cost of insurance has gone up at triple the rate of inflation. And wow, here is a shock, the three largest insurers had the highest premiums. So much for benefits of scale or leverage. But things are just as bad on the provider side, with a few large systems accounting for a large percent of all health care, inpatient and outpatient. And here is another shock, the largest systems charge the highest prices. Maybe there is some leverage from size on the provider side! Fee-for-service payment is most common, but there has been good growth in global or capitated-type payments or budgets. But there is a little good news–quality is above national averages for both payers and providers.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace